Metropolitan Life Insurance Company (MetLife)’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,049
| Closed | -$45.4K | – | 1571 |
|
|
2024
Q1 | $45.4K | Sell |
3,049
-429
| -12% | -$6.39K | ﹤0.01% | 1453 |
|
|
2023
Q4 | $63K | Hold |
3,478
| – | – | ﹤0.01% | 1319 |
|
|
2023
Q3 | $60.3K | Buy |
3,478
+389
| +13% | +$6.75K | ﹤0.01% | 1296 |
|
|
2023
Q2 | $56K | Buy |
+3,089
| New | +$56K | ﹤0.01% | 1360 |
|
|
2022
Q1 | – | Sell |
-7,310
| Closed | -$98.7K | – | 2574 |
|
|
2021
Q4 | $98.7K | Hold |
7,310
| – | – | ﹤0.01% | 2493 |
|
|
2021
Q3 | $123K | Hold |
7,310
| – | – | ﹤0.01% | 2404 |
|
|
2021
Q2 | $213K | Buy |
7,310
+362
| +5% | +$10.5K | ﹤0.01% | 2098 |
|
|
2021
Q1 | $273K | Buy |
6,948
+3,601
| +108% | +$142K | ﹤0.01% | 1799 |
|
|
2020
Q4 | $76K | Hold |
3,347
| – | – | ﹤0.01% | 2436 |
|
|
2020
Q3 | $75.8K | Buy |
+3,347
| New | +$75.8K | ﹤0.01% | 2369 |
|